SEM
Select Medical Holdings Corporation · Healthcare · Medical Care Facilities
Last
$16.39
$0.00 (0.00%) 4:00 PM ET
After hours $16.39 $0.00 (0.00%) 3:47 AM ET
Prev close $16.39
Open $16.39
Day high $16.41
Day low $16.38
Volume 1,966,738
Avg vol 2,780,534
Mkt cap
$2.03B
P/E ratio
14.25
FY Revenue
$5.45B
EPS
1.15
Gross Margin
11.54%
Sector
Healthcare
AI report sections
SEM
Select Medical Holdings Corporation
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+68% (Above avg)
Vol/Avg: 1.68×
RSI
67.43 (Strong)
Strong (60–70)
MACD momentum
Intraday
-0.00 (Weak)
MACD: 0.00 Signal: 0.00
Short-Term
-0.02 (Weak)
MACD: 0.10 Signal: 0.12
Long-Term
-0.01 (Weak)
MACD: 0.25 Signal: 0.26
Intraday trend score 65.00

Latest news

SEM 12 articles Positive: 2 Neutral: 0 Negative: 2
Negative GlobeNewswire Inc. • Halper Sadeh Llc
Halper Sadeh LLC is Investigating Whether SEM, FONR, NWE are Obtaining Fair Deals for their Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating Select Medical Holdings Corporation, FONAR Corporation, and NorthWestern Energy Group for potential violations of federal securities laws and breaches of fiduciary duties. The firm is examining whether shareholders are receiving fair consideration in proposed transactions involving company insiders and executives.

SEM FONR NWE shareholder rights securities investigation fiduciary duty merger and acquisition insider transactions
Sentiment note

Company is under investigation for potential securities law violations and breach of fiduciary duties related to a sale to insiders at $16.50 per share, raising concerns about fair dealing for shareholders.

Negative GlobeNewswire Inc. • Halper Sadeh Llc
Halper Sadeh LLC is Investigating Whether DAWN, SEM, EWCZ, FONR are Obtaining Fair Deals for their Shareholders

Investor rights law firm Halper Sadeh LLC is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed sales. The investigations focus on whether insiders are receiving preferential financial benefits and whether transaction terms may limit competing offers for Day One Biopharmaceuticals, Select Medical Holdings, European Wax Center, and FONAR Corporation.

DAWN SEM EWCZ FONR shareholder rights fiduciary duty securities violations merger investigation
Sentiment note

Under investigation for potential violations related to its sale to a consortium led by company executives and directors at $16.50 per share, raising concerns about insider conflicts of interest.

Positive Benzinga • Prnewswire
Select Medical Holdings Corporation Announces Declaration of a Special Stock Distribution to Spin-Off Concentra

Select Medical Holdings Corporation announced a special stock distribution to spin-off its Concentra subsidiary, which is the largest provider of occupational health services in the United States.

SEM CON Select Medical Holdings Corporation Concentra spin-off occupational health services
Sentiment note

The company is taking a strategic action to spin-off its Concentra subsidiary, which suggests a focus on streamlining its business and potentially unlocking value for shareholders.

Positive Zacks Investment Research • N/A
Select Medical (SEM) Expands Rehabilitation Services in Central PA - Zacks Investment Research

Select Medical Holdings Corporation (SEM) has collaborated with UPMC to open a satellite facility of the Helen M. Simpson Rehabilitation Hospital in the West Shore area of Central Pennsylvania. The new facility will provide inpatient rehabilitation services and is expected to improve access to care and continuity of care for patients in the region.

SEM Select Medical Holdings Corporation UPMC rehabilitation hospital satellite facility inpatient rehabilitation services
Sentiment note

The article highlights Select Medical's collaboration with UPMC to open a new satellite rehabilitation facility, which is expected to expand the company's footprint and improve access to care in the West Shore area of Central Pennsylvania. This move aligns with Select Medical's strategy to capitalize on the increased demand for specialized inpatient rehabilitation services.

Unknown Zacks Investment Research • Zacks Equity Research
Here's Why Select Medical (SEM) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

SEM
Unknown Zacks Investment Research • Zacks Equity Research
Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

SEM
Unknown Zacks Investment Research • Zacks Equity Research
Why Select Medical (SEM) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

SEM
Unknown Zacks Investment Research • Zacks Equity Research
Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?

Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.

BKD SEM HQY SERA
Unknown Zacks Investment Research • Zacks Equity Research
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

SEM
Unknown Zacks Investment Research • Zacks Equity Research
Here's Why Select Medical (SEM) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

SEM
Unknown Zacks Investment Research • Zacks Equity Research
Here's Why Select Medical (SEM) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

SEM
Unknown Zacks Investment Research • Zacks Equity Research
Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat

Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.

MOH CI CNC SEM
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal